Reason for request
Renouvellement d'inscription
Clinical Benefit
Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
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
j5DqEb2MTrN0wtX1